Compounders Research Compare

Oncolytics Biotech Inc.(ONCY)

Biotechnology · San Diego, CA

$0.60+0.00 (+0.03%)

Delayed quote: Oct 6, 2026, 2:29 PM EDT

About Oncolytics Biotech Inc.

Oncolytics Biotech Inc., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments. The company develops pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative advanced and metastatic breast cancer, metastatic pancreatic ductal adenocarcinoma, and anal cancer. It has an agreement with Roche Holding AG to supply its immune checkpoint inhibitors, atezolizumab, for use in its ongoing sponsored studies. Oncolytics Biotech Inc. was incorporated in 1998 and is headquartered in Calgary, Canada.

San Diego, CA

29 employees

www.oncolyticsbiotech.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Jared Kelly

View full financials

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T18:32:29.369Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:32:29.369Z.

Quote observation: 2026-10-06T18:29:38.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -0.26972318
Quote price: 0.5971

FMP input reference: d71c6897c98d436948f76d79272a6a7ae3c560285f8867db41996dc6a6301e16

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

ONCY Earnings Yield Metrics

EARNINGS YIELD

N/A

ONCY Competitors' Earnings Yield

Oncolytics Biotech Inc.

Current

Market Cap

$59.93M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Adicet Bio, Inc.

Market Cap

$59.81M

Earnings Yield

N/A

TTM Avg

0.93%

3Y Avg

0.93%

5Y Avg

0.93%

Kalaris Therapeutics Inc

Market Cap

$60.68M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Xilio Therapeutics, Inc.

Market Cap

$60.03M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Connect Biopharma Holdings Limited

Market Cap

$59.09M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MiNK Therapeutics, Inc.

Market Cap

$58.69M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Fractyl Health, Inc.

Market Cap

$61.21M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Boundless Bio, Inc.

Market Cap

$57.98M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PDS Biotechnology Corporation

Market Cap

$57.88M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

RenovoRx, Inc.

Market Cap

$62.85M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Oncolytics Biotech Inc. (ONCY)	$59.93M	N/A	N/A	N/A	N/A
Adicet Bio, Inc. (ACET)vs ›	$59.81M	N/A	0.93%	0.93%	0.93%
Kalaris Therapeutics Inc (KLRS)vs ›	$60.68M	N/A	N/A	N/A	N/A
Xilio Therapeutics, Inc. (XLO)vs ›	$60.03M	N/A	N/A	N/A	N/A
Connect Biopharma Holdings Limited (CNTB)vs ›	$59.09M	N/A	N/A	N/A	N/A
MiNK Therapeutics, Inc. (INKT)vs ›	$58.69M	N/A	N/A	N/A	N/A
Fractyl Health, Inc. (GUTS)vs ›	$61.21M	N/A	N/A	N/A	N/A
Boundless Bio, Inc. (BOLD)vs ›	$57.98M	N/A	N/A	N/A	N/A
PDS Biotechnology Corporation (PDSB)vs ›	$57.88M	N/A	N/A	N/A	N/A
RenovoRx, Inc. (RNXT)vs ›	$62.85M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics